摘要
背景:腹主动脉瘤(AAA)是一种导致65岁以上老年人死亡的退行性疾病,活性氧自由基(Ros)增加和氧化应激在AAA发病中起着重要作用。实验模型显示主动脉组织中有多种促肾上腺皮质激素(OS)的来源:炎症、NAD(P)h或NOx活性增高、诱导型一氧化氮合酶(INOS)过度表达、内皮型一氧化氮合酶(ENOS)解偶联、血小板活化和血红蛋白释放。 目的:人类研究证实氧化应激和内皮功能障碍是ROS产生的重要来源,与AAA的发展有着密切的关系。因此,通过抗氧化剂减少氧化应激可以是限制AAA发展的好策略。本研究的目的是审查有利于或不支持这样的假设的文献数据。目前还没有证据表明,使用经典的低分子量抗氧化剂(维生素c和e,β-胡萝卜素)作为促肾上腺皮质激素治疗的靶点是有效的。然而,最近的流行病学数据显示,富含抗氧化多酚的水果饮食通过激活Keap 1/Nrf 2/ARE途径恢复内皮功能和刺激酶促抗氧化剂的能力而发挥着积极的作用,多酚类化合物可以成为减少人类AAA进展的一个有希望的治疗靶点。 结论:临床研究迫切需要证实多酚类物质在预防或限制AAA中的潜在有益作用。
关键词: 实验性和人腹主动脉瘤,内皮功能,氧化应激,抗氧化剂,多酚,预防。
图形摘要
Current Drug Targets
Title:Abdominal Aortic Aneurysm (AAA): Is There a Role for the Prevention and Therapy Using Antioxidants?
Volume: 19 Issue: 11
关键词: 实验性和人腹主动脉瘤,内皮功能,氧化应激,抗氧化剂,多酚,预防。
摘要: Background: Abdominal aortic aneurysm (AAA) is a degenerative disease that causes mortality in people aged > 65 years. Increased reactive oxygen species (ROS) and oxidative stress seem to play a pivotal role in AAA pathogenesis. Several sources of ROS have been identified in aortic tissues using experimental models: inflammation, increased activity of NAD(P)H or NOX, over-expression of inducible nitric oxide synthase (iNOS), uncoupled endothelial nitric oxide synthase (eNOS), platelets activation and iron release from hemoglobin.
Objectives: Human studies confirmed that oxidative stress and endothelial dysfunction, an important source of ROS production, were well associated with AAA development. Reducing oxidative stress by antioxidants can therefore be a good strategy for limiting AAA development. The objective of the present study is to review literature data favoring or not such a hypothesis. There is currently no evidence showing that strategies using classical low molecular weight antioxidants (vitamins C and E, β- carotene) as target for ROS is effective to reduce human AAA progression. However, recent epidemiological data have highlighted the positive role of a diet enriched in fruits which contain high amounts of antioxidant polyphenols. By their ability to restore endothelial function and also their capacity to stimulate enzymatic antioxidants through activation of the Keap1/Nrf2/ARE pathway, polyphenols can represent a promising treatment target for reducing human AAA progression.
Conclusion: Clinical studies are therefore urgently necessary to confirm the potential beneficial effect of polyphenols in preventing or limiting AAA.
Export Options
About this article
Cite this article as:
Abdominal Aortic Aneurysm (AAA): Is There a Role for the Prevention and Therapy Using Antioxidants?, Current Drug Targets 2018; 19 (11) . https://dx.doi.org/10.2174/1389450118666170918164601
DOI https://dx.doi.org/10.2174/1389450118666170918164601 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Graphical Abstracts:
Current Medical Imaging NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review
Current Neuropharmacology The Genetics of Vascular Complications in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Current Hypertension Reviews Mechanosensitive Channels: Therapeutic Targets in the Myocardium?
Current Pharmaceutical Design Intracoronary Brachytherapy - Clinical State and Pathophysiological Considerations
Current Pharmaceutical Design Significant Association of CXCL12 rs1746048 with LDL-C Level in Intracranial Aneurysms
Current Neurovascular Research Long Term Safety and Efficacy of Internal Carotid Artery Adventitial Stripping in Carotid Sinus Syndrome
Current Hypertension Reviews Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) A Clinical Perspective of Soluble Epoxide Hydrolase Inhibitors in Metabolic and Related Cardiovascular Diseases
Current Molecular Pharmacology Alogliptin; A Review of a New Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Cardiovascular & Hematological Disorders-Drug Targets Review of Some Recent Patents on the Large-Eddy Simulation Technique in Turbulence
Recent Patents on Mechanical Engineering Application of Current Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy in Every Day Clinical Practice
Current Pharmaceutical Design Which way in? The Necessity of Multiple Approaches to Transcatheter Valve Therapy
Current Cardiology Reviews IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Cardiovascular Risk Calculators and their Applicability to South Asians
Current Diabetes Reviews A Cyclooxygenase-2 Inhibitor Reduces Vascular Wall Thickness and Ameliorates Cognitive Impairment in a Cerebral Small Vessel Diseases Rat Model
Current Alzheimer Research Passive Smoking and Coronary Heart Disease
Current Vascular Pharmacology Drug-Eluting Stents: Present and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry Progression of Alzheimer-type Neurofibrillary Tangles is Related to the Proximodistal Segments of the Hemispheric Arteries
Current Alzheimer Research